About the Molecular Imaging Program at Stanford
The Molecular Imaging Program at Stanford (MIPS) was established as an inter-disciplinary program in 2003 by the Dean of the School of Medicine (Dr. Philip Pizzo) and brings together scientists and physicians who share a common interest in developing and using state-of-the-art imaging technology and developing molecular imaging assays for studying intact biological systems. The program is directed by Dr. Sanjiv Sam Gambhir, Virginia & D.K. Ludwig Professor of Cancer Research and Chair of the Department of Radiology.
Director, Molecular Imaging Program at Stanford
- Virginia & D.K. Ludwig Professor of Cancer Research
- Chair, Department of Radiology
- Professor by courtesy, Departments of Bioengineering and Materials Science & Engineering
- Director, Canary Center at Stanford for Cancer Early Detection
The MIPS Program has five key research areas focusing on:
- synthesis and validation of radiolabeled and fluorescent molecular probes for molecular imaging
- development of molecular imaging instrumentation for living subjects
- development of molecular imaging approaches/assays for interrogating cellular events in living subjects
- development of software tools for visualization and analysis of molecular imaging data
- merger of therapeutics and imaging strategies for improved patient management
Funding for the Program's research activities come from a mix of Federal (National Institutes of Health and Department of Energy), Foundation and University sources, as well as through a number of collaborations with Industry.
The Program attracts graduate students from a wide range of programs including Molecular Pharmacology, Cell/Molecular Biology, Electrical Engineering, and Bio-Engineering.
The Program runs several state-of-the-art imaging facilities within the Clark small animal imaging core including digital whole body autoradiography (DWBA), magnetic resonance imaging (MRI), microPET, microSPECT/CT, optical bioluminescence/fluorescence and ultrasound.